Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Pre-gestational diabetes mellitus is associated with increased risk of maternal and perinatal adverse outcomes. This systematic review was conducted to evaluate the effectiveness and safety of pre-conception care (PCC) in improving maternal and perinatal outcomes. METHODS: Databases from MEDLINE, EMBASE, WEB OF SCIENCE, and Cochrane Library were searched, including the CENTRAL register of controlled trials, and CINHAL up until March 2019, without any language restrictions, for any pre-pregnancy care aiming at health promotion, glycemic control, and screening and treatment of diabetes complications in women with type I or type II pre-gestational diabetes. Trials and observational studies were included in the review. Newcastle-Ottawa scale and the Cochrane collaboration methodology for data synthesis and analysis were used, along with the GRADE tool to evaluate the body of evidence. RESULTS: The search identified 8500 potentially relevant citations of which 40 reports of 36 studies were included. The meta-analysis results show that PCC reduced congenital malformations risk by 71%, (Risk ratio (RR) 0.29; 95% CI: 0.21-0.40, 25 studies; 5903 women; high-certainty evidence). The results also show that PCC may lower HbA1c in the first trimester of pregnancy by an average of 1.27% (Mean difference (MD) 1.27; 95% CI: 1.33-1.22; 4927 women; 24 studies, moderate-certainty evidence). Furthermore, the results suggest that PCC may lead to a slight reduction in the risk of preterm delivery of 15%, (RR 0.85; 95% CI: 0.73-0.99; nine studies, 2414 women; moderate-certainty evidence). Moreover, PCC may result in risk reduction of perinatal mortality by 54%, (RR 0.46; 95% CI: 0.30-0.73; ten studies; 3071 women; moderate-certainty evidence). There is uncertainty about the effects of PCC on the early booking for antenatal care (MD 1.31; 95% CI: 1.40-1.23; five studies, 1081 women; very low-certainty evidence) and maternal hypoglycemia in the first trimester, (RR 1.38; 95% CI: 1.07-1.79; three studies; 686 women; very low- certainty evidence). In addition, results of the meta-analysis indicate that PCC may lead to 48% reduction in the risk of small for gestational age (SGA) (RR 0.52; 95% CI: 0.37-0.75; six studies, 2261 women; moderate-certainty evidence). PCC may reduce the risk of neonatal admission to intensive care unit (NICU) by 25% (RR 0.75; 95% CI: 0.67-0.84; four studies; 1322 women; moderate-certainty evidence). However, PCC may have little or no effect in reducing the cesarean section rate (RR 1.02; 95% CI: 0.96-1.07; 14 studies; 3641 women; low-certainty evidence); miscarriage rate (RR 0.86; 95% CI: 0.70-1.06; 11 studies; 2698 women; low-certainty evidence); macrosomia rate (RR 1.06; 95% CI: 0.97-1.15; nine studies; 2787 women, low-certainty evidence); neonatal hypoglycemia (RR 0.93; 95% CI: 0.74-1.18; five studies; 880 women; low-certainty evidence); respiratory distress syndrome (RR 0.78; 95% CI: 0.47-1.29; four studies; 466 women; very low-certainty evidence); or shoulder dystocia (RR 0.28; 95% CI: 0.07-1.12; 2 studies; 530 women; very low-certainty evidence). CONCLUSION: PCC for women with pre-gestational type 1 or type 2 diabetes mellitus is effective in improving rates of congenital malformations. In addition, it may improve the risk of preterm delivery and admission to NICU. PCC probably reduces maternal HbA1C in the first trimester of pregnancy, perinatal mortality and SGA. There is uncertainty regarding the effects of PCC on early booking for antenatal care or maternal hypoglycemia during the first trimester of pregnancy. PCC has little or no effect on other maternal and perinatal outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Preconception counseling is also associated with reductions in perinatal mortality and small-for-gestational-age birth weight (18).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Preconception counseling for pregnant people with preexisting type 1 or type 2 diabetes is highly effective in reducing the risk of congenital malformations and decreasing the risk of preterm delivery and admission to neonatal intensive care units.”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The preconception care of people with known preexisting diabetes results in lower A1C and reduced risk of birth defects, preterm delivery, perinatal mortality, small-for-gestational-age birth weight, and neonatal intensive care unit admission (173).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [173]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“as the preconception care of people with preexisting diabetes results in lower A1C and reduced risk of birth defects, preterm delivery, perinatal mortality, small-forgestational-age birth weight, and neonatal intensive care unit admission (188).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [188]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“results from in-school nutrition and lifestyle education programs have been inconsistent.1525–1531”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1528]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1×
“Additionally, with the increased recognition of the importance of evaluation of the body of evidence a grading tool, Grading of Recommendations Assessment, Development and Evaluation (GRADE), has been introduced to facilitate evidence-based decision making for interventions in clinical medicine and health policy [17].”
MethodEpidemiology and causes of preterm birth
Goldenberg, R. L., Culhane, J. F., Iams, J. D., & Romero, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60074-4 · Cited by 7,801 · cited 1×
“The etiology of preterm birth is complex and many medical, socioeconomic, and psychological factors interplay in the causation of preterm delivery [83].”
Background(1996) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1111/j · Cited by 5,486
An overview of mortality and sequelae of preterm birth from infancy to adulthood
Saigal, S., & Doyle, L. W. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60136-1 · Cited by 2,818 · cited 1×
“leading cause of under-five mortality and one of the main causes of both short and long-term morbidity [85, 86].”
BackgroundChawanpaiboon, S., Vogel, J. P., Moller, A.-B., Lumbiganon, P., Petzold, M., Hogan, D., Landoulsi, S., Jampathong, N., Kongwattanakul, K., Laopaiboon, M., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30451-0 · Cited by 2,572 · cited 1×
“84 million preterm live births were born in the year 2014, with the majority born in low- and middle-income countries [84].”
BackgroundOxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232 · cited 1×
“Evidence from clinical and experimental studies showed that hyperglycemia leads to the production of reactive oxygen species and depletion of antioxidants, which in turn causes intracellular oxidative stress, cell injury and cell death at the time of organogenesis [74, 75].”
BackgroundUnintended pregnancy in the United States: incidence and disparities, 2006
Finer, L. B., & Zolna, M. R. (2011) · Contraception · doi:10.1016/j.contraception.2011.07.013 · Cited by 1,291
Evers, I. M., de Valk, H. W., & Visser, G. H. A. (2004) · BMJ · doi:10.1136/bmj.38043.583160.ee · Cited by 775 · cited 3×
“9 Evers (2004) Netherland [47] PCC: 271 women with (DM-I) NO-PCC: 52 women with (DM-I) PCC included: • Planned pregnancy, • Folic acid supplementation, • Glycemic control.”
BackgroundInfluentialDiabetes in sub-Saharan Africa
Mbanya, J. C. N., Motala, A. A., Sobngwi, E., Assah, F. K., & Enoru, S. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60550-8 · Cited by 775 · cited 1×
“Furthermore, in low and middle-income countries, the burden of diabetes is higher among the younger population, including women in the reproductive age group [2].”
BackgroundTerrin, N., Schmid, C. H., & Lau, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.006 · Cited by 492 · cited 1×
“Analysis of the effect on HbA1C, showed asymmetrical distribution of the studies (Fig 10C), however this can be explained by the marked heterogeneity associated with this outcome [69].”
BackgroundWellings, K., Jones, K. G., Mercer, C. H., Tanton, C., Clifton, S., Datta, J., Copas, A. J., Erens, B., Gibson, L. J., Macdowall, W., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62071-1 · Cited by 477
Prevention of Congenital Malformations in Infants of Insulin-dependent Diabetic Mothers
Fuhrmann, K., Reiher, H., Semmler, K., Fischer, F., Fischer, M., & Glöckner, E. (1983) · Diabetes Care · doi:10.2337/diacare.6.3.219 · Cited by 440 · cited 1×
“Among these reports, three articles described the same cohort study with two interim [27, 28] and one final report [29], one study reported the outcomes of the same cohort in two articles [30, 31] and two articles reported the outcomes of one cohort with one interim [32] and one final report [33].”
ResultPreconception Care of Diabetes: Glycemic Control Prevents Congenital Anomalies
Kitzmiller, J. L. (1991) · JAMA · doi:10.1001/jama.1991.03460060063025 · Cited by 397 · cited 10×
“PCC: x First trimester HbA1c: 6.15 ± SD 0.82 (N = 43) NO-PCC: x First trimester HbA1c: 8.13 ± SD 01.85 (N = 108) 28 Rosenn (1991) USA[39] PCC: 28 women with (DM-I) NO-PCC: 71 women with (DM-I) PCC included: • Dietary advice • Glycemic control PCC: First trimester HbA1c:8.5 ± SD 0.22 (N = 28) Congenital malformations:…”
BackgroundInfluentialPregnancy outcomes in the Diabetes Control and Complications Trial
(1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70683-x · Cited by 278
Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease: A Nationwide Cohort Study
Øyen, N., Diaz, L. J., Leirgul, E., Boyd, H. A., Priest, J., Mathiesen, E. R., Quertermous, T., Wohlfahrt, J., & Melbye, M. (2016) · Circulation · doi:10.1161/circulationaha.115.017465 · Cited by 261 · cited 1×
“Maternal hyperglycemia at the time of organogenesis is the main teratogen [72, 73].”
BackgroundWilson, R. D., Wilson, R. D., Audibert, F., Brock, J.-A., Carroll, J., Cartier, L., Gagnon, A., Johnson, J.-A., Langlois, S., Murphy-Kaulbeck, L., et al. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30230-9 · Cited by 259
French Multicentric Survey of Outcome of Pregnancy in Women With Pregestational Diabetes
Diabetes and Pregnancy Group, F. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.2990 · Cited by 257 · cited 8×
“PCC: x First trimester HbA1c: 6.24 ± SD 0.69 (N = 99) NO-PCC: x First trimester HbA1c: 6.24 ± SD 0.7 (N = 223) 17 Hiéronimus (2004) France [46] PCC: 24 women with (DM-I and DM-II) NO-PCC: 36 women with (DM-I and DM-II) PCC included: Pregnancy programming: - • Pre-conceptional specialized consultation, • Intensificati…”
BackgroundMethodInfluentialInkster, M. E., Fahey, T. P., Donnan, P. T., Leese, G. P., Mires, G. J., & Murphy, D. J. (2006) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-6-30 · Cited by 233 · cited 1×
“Many studies confirmed the incremental increase in the rate of adverse pregnancy outcomes, among women with diabetes, with the increase in the level of HbA1c [78–81] and the significant risk reduction in congenital malformations with one percent reduction in HbA1c level [82].”
BackgroundCardiovascular malformations in infants of diabetic mothers
Wren, C., Birrell, G., & Hawthorne, G. (2003) · Heart · doi:10.1136/heart.89.10.1217 · Cited by 229
Wahabi, H. A., Alzeidan, R. A., Bawazeer, G. A., Alansari, L. A., & Esmaeil, S. A. (2010) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-10-63 · Cited by 228 · cited 3×
“The results of this review concur with previously published reviews on the effectiveness of PCC [9, 16].”
BackgroundResultSelf-citationJensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., & Damm, P. (2009) · Diabetes Care · doi:10.2337/dc08-2061 · Cited by 227
Can prepregnancy care of diabetic women reduce the risk of abnormal babies?
Steel, J. M., Johnstone, F. D., Hepburn, D. A., & Smith, A. F. (1990) · BMJ · doi:10.1136/bmj.301.6760.1070 · Cited by 205 · cited 14×
“The least reported outcomes were maternal hypoglycemia in three studies (all reported results among type 1 diabetes) [31, 33, 51] and shoulder dystocia in two studies [50, 65].”
BackgroundResultInfluentialEffectiveness of a Regional Prepregnancy Care Program in Women With Type 1 and Type 2 Diabetes
Murphy, H. R., Roland, J. M., Skinner, T. C., Simmons, D., Gurnell, E., Morrish, N. J., Soo, S.-C., Kelly, S., Lim, B., Randall, J., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1113 · Cited by 186 · cited 24×
“PCC: Miscarriage: (28/181) LGA: (120/145) Congenital malformations: (1/ 152) Perinatal mortality: (1/152) CS delivery: (99/181) Preterm delivery: (50/150) SGA: (7/145) NO-PCC: Miscarriage: (71/495) LGA: (284/372) Congenital malformations: (23/ 408) Perinatal mortality: (9/408) CS delivery: (222/495) Preterm delivery:…”
BackgroundInfluentialPrepregnancy Care and Pregnancy Outcomes in Women With Type 1 Diabetes
Temple, R. C., Aldridge, V. J., & Murphy, H. R. (2006) · Diabetes Care · doi:10.2337/dc05-2265 · Cited by 184
Why Don't Women With Diabetes Plan Their Pregnancies?
Holing, E. V., Beyer, C. S., Brown, Z. A., & Connell, F. A. (1998) · Diabetes Care · doi:10.2337/diacare.21.6.889 · Cited by 182
Willhoite, M. B., Bennert, H. W., Palomaki, G. E., Zaremba, M. M., Herman, W. H., Williams, J. R., & Spear, N. H. (1993) · Diabetes Care · doi:10.2337/diacare.16.2.450 · Cited by 176
Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis
Gabbay-Benziv, R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.481 · Cited by 170
RETIRED: Teratogenicity Associated With Pre-Existing and Gestational Diabete
Allen, V. M., Armson, B. A., Wilson, R. D., Allen, V. M., Blight, C., Gagnon, A., Johnson, J.-A., Langlois, S. F., Summers, A. M., WYATT, P. R., et al. (2007) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32653-6 · Cited by 160
Temple, R., Aldridge, V., Greenwood, R., Heyburn, P., Sampson, M., & Stanley, K. (2002) · BMJ · doi:10.1136/bmj.325.7375.1275 · Cited by 152 · cited 1×
“Hyperglycemia in early pregnancy increases the risk of congenital abnormalities by ninefold compared to the normoglycemic population [3].”
BackgroundDiabetes mellitus and the risk of preterm birth with regard to the risk of spontaneous preterm birth
Köck, K., Köck, F., Klein, K., Bancher‐Todesca, D., & Helmer, H. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903551392 · Cited by 148
Goldman, J. A., Dicker, D., Feldberg, D., Yeshaya, A., Samuel, N., & Karp, M. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90812-4 · Cited by 145
HbA1c in Early Diabetic Pregnancy and Pregnancy Outcomes
Nielsen, G. L., Møller, M., & Sørensen, H. T. (2006) · Diabetes Care · doi:10.2337/dc06-0914 · Cited by 140
Diabetes and Pregnancy: Factors associated with seeking pre-conception care
Janz, N. K., Herman, W. H., Becker, M. P., Charron-Prochownik, D., Shayna, V. L., Lesnick, T. G., Jacober, S. J., Fachnie, J. D., Kruger, D. F., Sanfield, J. A., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.2.157 · Cited by 136
Fuhrmann, K., Reiher, H., Semmler, K., & Glöckner, E. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1210327 · Cited by 133 · cited 1×
“Among these reports, three articles described the same cohort study with two interim [27, 28] and one final report [29], one study reported the outcomes of the same cohort in two articles [30, 31] and two articles reported the outcomes of one cohort with one interim [32] and one final report [33].”
ResultPeterson, C., Grosse, S. D., Li, R., Sharma, A. J., Razzaghi, H., Herman, W. H., & Gilboa, S. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.09.009 · Cited by 130
Wahabi, H. A., Alzeidan, R. A., & Esmaeil, S. A. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-792 · Cited by 126 · cited 2×
“The results of this review concur with previously published reviews on the effectiveness of PCC [9, 16].”
BackgroundResultSelf-citationDamm, P., & Mølsted‐Pedersen, L. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90656-x · Cited by 116
Association Between Congenital Heart Defects and Small for Gestational Age
Malik, S., Cleves, M. A., Zhao, W., Correa, A., Hobbs, C. A., & Study, A. T. N. B. D. P. (2007) · Pediatrics · doi:10.1542/peds.2006-2742 · Cited by 115 · cited 1×
“The association between SGA and congenital malformations, especially those for the heart and the urinary tract, has been documented in published reports [88, 89].”
ResultStillbirth in diabetic pregnancies
Mathiesen, E. R., Ringholm, L., & Damm, P. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2010.11.001 · Cited by 102
Personal experiences of women with diabetes who do not attend pre‐pregnancy care
Murphy, H. R., Temple, R. C., Ball, V. E., Roland, J. M., Steel, S., Zill‐E‐Huma, R., Simmons, D., Royce, L. R., Skinner, T. C., & on behalf of the East Anglia Study group for Improving Pregnancy Outcomes in women with Diabetes (EASIPOD) (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02890.x · Cited by 99 · cited 1×
“Most pregnancies are unplanned, which makes PCC unfeasible for almost 40% of women with pregestational diabetes [14].”
BackgroundPre‐conception management of insulin‐dependent diabetes: Improvement of pregnancy outcome
Rosenn, B., Miodovnik, M., Combs, C., Khoury, J., & Siddiqi, T. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90749-9 · Cited by 94 · cited 10×
“c Downgraded to very low-grade due to the high risk of bias in the study with the largest weight [39] and high unexplained heterogeneity d Upgraded to moderate-certainty level because of low bias (77% of the participants were from studies at low risk of bias), while heterogeneity can be explained by long”
BackgroundMethodInfluentialHoang, T. T., Marengo, L. K., Mitchell, L. E., Canfield, M. A., & Agopian, A. J. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx033 · Cited by 91
Yang, P., Reece, E. A., Wang, F., & Gabbay-Benziv, R. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.11.036 · Cited by 90
Study of the costs and morbidities of late-preterm birth
Bérard, A., Le Tiec, M., & De Vera, M. A. (2012) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fetalneonatal-2011-300969 · Cited by 89 · cited 1×
“In addition, preterm birth is associated with high cost to the health system and the families of the preterm born infant [87].”
BackgroundLudvigsson, J. F., Neovius, M., Söderling, J., Gudbjörnsdottir, S., Svensson, A.-M., Franzén, S., Stephansson, O., & Pasternak, B. (2018) · BMJ · doi:10.1136/bmj.k2638 · Cited by 86
Five years' experience of a "prepregnancy" clinic for insulin-dependent diabetics.
Steel, J. M., Johnstone, F. D., Smith, A. F., & Duncan, L. J. (1982) · BMJ · doi:10.1136/bmj.285.6338.353 · Cited by 81
Wender-Ożegowska, E., Wróblewska‐Seniuk, K., Zawiejska, A., Pietryga, M., Szczapa, J., & Biczysko, R. (2004) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2005.00606.x · Cited by 75 · cited 1×
“Education about the interaction between diabetes and pregnancy, family planning combined with diabetes self-management skills can achieve optimum glycemic control during early pregnancy, which can reduce rates of congenital abnormalities and perinatal mortality [10].”
BackgroundAnalysis of neonatal morbidity and mortality in late-preterm newborn infants
Araújo, B. F. D., Zatti, H., Madi, J. M., Coelho, M. B., Olmi, F. B., & Canabarro, C. T. (2012) · Jornal de Pediatria · doi:10.2223/jped.2196 · Cited by 74
Diabetes and pregnancy. Preconception care, pregnancy outcomes, resource utilization and costs.
Herman, W. H., Janz, N. K., Becker, M. P., & Charron‐Prochownik, D. (1999) · PubMed · Cited by 74
Outcome of fetuses in women with pregestational diabetes mellitus
Galindo, A., Burguillo, A. G., Azriel, S., & Fuente, P. D. L. (2006) · Journal of Perinatal Medicine · doi:10.1515/jpm.2006.062 · Cited by 73 · cited 4×
“11 Galindo (2006) Spain[48] PCC: 15 women with (DM-I and DM-II) NO-PCC: 111 women with (DM-I and DM-II) PCC included: • Education, • Glycemic control, • Self-monitoring of blood glucose.”
BackgroundInfluentialA Prepregnancy Care Program for Women With Diabetes: Effective and Cost Saving
Egan, A. M., Danyliv, A., Carmody, L. A., Kirwan, B., & Dunne, F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4046 · Cited by 67 · cited 27×
“PCC: Miscarriage: (28/181) LGA: (120/145) Congenital malformations: (1/ 152) Perinatal mortality: (1/152) CS delivery: (99/181) Preterm delivery: (50/150) SGA: (7/145) NO-PCC: Miscarriage: (71/495) LGA: (284/372) Congenital malformations: (23/ 408) Perinatal mortality: (9/408) CS delivery: (222/495) Preterm delivery:…”
BackgroundInfluentialCyganek, K., Hebda-Szydlo, A., Katra, B., Skupien, J., Klupa, T., Janas, I., Kaim, I., Sieradzki, J., Reron, A., & Malecki, M. T. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0081 · Cited by 65 · cited 1×
“…dystocia: (6/265) # Perinatal mortality: (8/265) ~LGA: (75/265) SGA: (20/265) Excessive GWG: (80/265) Neonatal hypoglycemia: (22/ 265) NICU admission: (137/265) 6 Cyganek (2010) Poland [58] PCC: 116 women with (DM-I) NO-PCC: 153 women with (DM-I) PCC included: • Intensive diabetes management.”
Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes
Temple, R., Aldridge, V, Stanley, K., & Murphy, H. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01071.x · Cited by 63 · cited 12×
“PCC: x First trimester HbA1c: 6.15 ± SD 0.82 (N = 43) NO-PCC: x First trimester HbA1c: 8.13 ± SD 01.85 (N = 108) 28 Rosenn (1991) USA[39] PCC: 28 women with (DM-I) NO-PCC: 71 women with (DM-I) PCC included: • Dietary advice • Glycemic control PCC: First trimester HbA1c:8.5 ± SD 0.22 (N = 28) Congenital malformations:…”
ResultInfluentialHypoglycemia in Type 1 Diabetic Pregnancy
Heller, S., Damm, P., Mersebach, H., Skjøth, T. V., Kaaja, R., Hod, M., Durán-García, S., McCance, D., & Mathiesen, E. R. (2010) · Diabetes Care · doi:10.2337/dc09-1605 · Cited by 63 · cited 21×
“PCC: Miscarriage: (28/181) LGA: (120/145) Congenital malformations: (1/ 152) Perinatal mortality: (1/152) CS delivery: (99/181) Preterm delivery: (50/150) SGA: (7/145) NO-PCC: Miscarriage: (71/495) LGA: (284/372) Congenital malformations: (23/ 408) Perinatal mortality: (9/408) CS delivery: (222/495) Preterm delivery:…”
BackgroundMethodInfluentialYamamoto, J. M., Hughes, D. J., Evans, M. L., Vithian, K., Clark, J. D. A., Morrish, N. J., Rayman, G. A., Winocour, P. H., Hambling, C. E., Harries, A. W., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4613-3 · Cited by 60
Outcome of fetuses in women with pregestational diabetes mellitus
Artal, R. (2006) · Journal of Perinatal Medicine · doi:10.1515/jpm.2006.063 · Cited by 55
Ray, J. G., Vermeulen, M. J., Meier, C., & Wyatt, P. R. (2004) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hch107 · Cited by 54
Pre-conception diabetes care in insulin-dependent diabetes mellitus
Dunne, F. P. (1999) · QJM · doi:10.1093/qjmed/92.3.175 · Cited by 52
Dicker, D., Feldberg, D., Samuel, N., Yeshaya, A., Karp, M., & Goldman, J. A. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90245-1 · Cited by 50 · cited 5×
“PCC: Miscarriage: (13/66) CS delivery: (47/66) Congenital malformations: (2/ 66) RDS: (6/66) Neonatal Hypoglycemia: (14/66) Preterm delivery: (15/66) Perinatal mortality: (1/66) SGA: (1/54) NO-PCC: Miscarriage: (15/119) CS delivery: (65/119) Congenital malformations: (10/ 119) RDS: (12/119) Neonatal Hypoglycemia: (30/…”
BackgroundInfluentialCousins, L. M. (1991) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80106-3 · Cited by 43 · cited 1×
“PCC: Perinatal mortality: (3/175) Congenital malformations: (2/ 175) NO-PCC: Perinatal mortality: (16/260) Congenital malformations: (16/ 260) 2 Cousins (1991) USA[37] PCC: 27 women with (DM-I and DM-II) NO-PCC: 347 women with (DM-I and DM-II) received care after conception PCC included: • A…”
BackgroundPregnancy planning in type 1 diabetic women improves glycemic control and pregnancy outcomes
Kekäläinen, P., Juuti, M., Walle, T., & Laatikainen, T. K. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1081888 · Cited by 42
The experiences of prepregnancy care for women with type 2 diabetes mellitus: a meta-synthesis
Forde, R., Patelarou, E., & Forbes, A. (2016) · International Journal of Women s Health · doi:10.2147/ijwh.s115955 · Cited by 42
Neff, K., Forde, R., Gavin, C., Byrne, M. M., Firth, R. G., Daly, S., McAuliffe, F. M., Foley, M., Coffey, M., Coulter-Smith, S., et al. (2013) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-013-1027-6 · Cited by 38 · cited 24×
“PCC: Miscarriage: (28/181) LGA: (120/145) Congenital malformations: (1/ 152) Perinatal mortality: (1/152) CS delivery: (99/181) Preterm delivery: (50/150) SGA: (7/145) NO-PCC: Miscarriage: (71/495) LGA: (284/372) Congenital malformations: (23/ 408) Perinatal mortality: (9/408) CS delivery: (222/495) Preterm delivery:…”
BackgroundInfluentialEffect of pregnancy planning on maternal and neonatal outcomes in women with Type 1 diabetes
Wotherspoon, A. C., Young, I. S., Patterson, C. C., McCance, D. R., Holmes, V. A., & the Diabetes and Pre‐eclampsia Intervention Trial (DAPIT) Study Group (2017) · Diabetic Medicine · doi:10.1111/dme.13398 · Cited by 38
Preconception Care of Women With Diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s91 · Cited by 38
Outcome of pregnancies complicated by pre‐gestational diabetes mellitus
Gunton, J. E., McElduff, A., Sulway, M. J., Stiel, J. N., Kelso, I. M., Boyce, S., Fulcher, G. R., Robinson, B. G., Clifton-Bligh, P. B., & WILMSHURST, E. G. (2000) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2000.tb03164.x · Cited by 37
Perinatal mortality in diabetic pregnancy
Vitoratos, N., Vrachnis, N., Valsamakis, G., Panoulis, K., & Creatsas, G. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05670.x · Cited by 32 · cited 2×
“Congenital defects and preterm births [6] were the main contributors to the high rate of perinatal mortality observed in pregnancies complicated by maternal pregestational diabetes [7, 8].”
BackgroundDoes preconceptional counselling in diabetic women influence perinatal outcome?
García‐Patterson, A., Corcoy, R., Rigla, M., Caballero, A., Adelantado, J. M., Altirriba, O., & de Leiva, A. (1997) · PubMed · Cited by 31
Jensen, B. M., Kühl, C., Mølsted-Pedersen, L., Saurbrey, N., & Fog-Pedersen, J. (1986) · Acta Endocrinologica · doi:10.1530/acta.0.111s0081 · Cited by 30
Bánhidy, F. G., Dakhlaoui, A., Horváth–Puhó, E., & Czeizel, A. E. (2010) · Congenital Anomalies · doi:10.1111/j.1741-4520.2010.00302.x · Cited by 25 · cited 1×
“Another intervention with proven effectiveness in the prevention of congenital malformations in this high-risk group is preconception folic acid supplementation [76, 77].”
BackgroundWang, M., Athayde, N., Padmanabhan, S., & Cheung, N. W. (2019) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12936 · Cited by 24 · cited 1×
“Congenital malformations are one of the principal contributors to the high perinatal mortality observed in pregnancies complicated with pregestational diabetes [7, 8, 70, 71].”
BackgroundTeixeira, M. P. C., Queiroga, T. P. R., & Mesquita, M. D. A. (2016) · Einstein (São Paulo) · doi:10.1590/s1679-45082016ao3684 · Cited by 22 · cited 19×
“PCC: Miscarriage: (28/181) LGA: (120/145) Congenital malformations: (1/ 152) Perinatal mortality: (1/152) CS delivery: (99/181) Preterm delivery: (50/150) SGA: (7/145) NO-PCC: Miscarriage: (71/495) LGA: (284/372) Congenital malformations: (23/ 408) Perinatal mortality: (9/408) CS delivery: (222/495) Preterm delivery:…”
BackgroundInfluentialMaternal factors predictive of first‑trimester pregnancy loss in women with pregestational diabetes
Gutaj, P., Zawiejska, A., Wender-Ożegowska, E., & Brązert, J. (2013) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1585 · Cited by 21 · cited 7×
“27 Gutaj (2013) Poland[61] PCC: 43 women with (DM-I and DM-II) NO-PCC: 108 women with (DM-I and DM-II) PCC included: • Pregnancy planning, • Counseling delivered by a diabetes specialist, • Glycemic control by making necessary changes in pharmacotherapy, • Controlling chronic diabetic complications.”
BackgroundInfluentialKallas‐Koeman, M. M., Khandwala, F., & Donovan, L. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.07.003 · Cited by 20 · cited 4×
“…of diabetes, five of the 11 control women were treated in the diabetic clinic in the hospital before pregnancy so they knew about the importance of glycemic control Kallas-Koeman 2012[60] � � � � � � � � � 9 Low risk Kekäläinen 2016 [65] � � � � � � � � 8 Low risk Kitzmiller 1991 [38] �…”
BackgroundInfluentialGrossesse et diabète de type 2 : quel pronostic fœtal ?
Hiéronimus, S., Cupelli, C., Durand-Reville, M., Bongain, A., & Fénichel, P. (2003) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2003.10.023 · Cited by 19 · cited 5×
“Hiéronimus 2004[46] � � � Unclear Unclear � � � 6 High risk no description of the possible confounding factors or adjustment”
BackgroundInfluentialOutcome of pregnancy complicated by pre‐gestational diabetes – improvement in outcomes
Gunton, J. E., Morris, J. M., Boyce, S., Kelso, I. M., & McElduff, A. (2002) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.0004-8666.2002.00478.x · Cited by 19 · cited 5×
“15 Gunton (2002) Australia [44] PCC: 19 pregnancies (some participants had more than one pregnancy) with (DM-I and DM-II) NO-PCC: 16 pregnancies (some participants had more than one pregnancy) with (DM-I and DM-II) Total Number of women:31 PCC included: • Pregnancies planning by optimizing glycemic control before conc…”
BackgroundInfluentialHolmes, V. A., Hamill, L. L., Alderdice, F. A., Spence, M., Harper, R., Patterson, C. C., Loughridge, S., McKenna, S., Gough, A., & McCance, D. R. (2016) · Primary care diabetes · doi:10.1016/j.pcd.2016.07.005 · Cited by 19
Wong, V., Suwandarathne, H., & Russell, H. (2013) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12044 · Cited by 18 · cited 15×
“33 Wong (2013) United Kingdom[62] PCC: 52 women with (DM-I and DM-II) NO-PCC: 109 women with (DM-I and DM-II) PCC included: • HbA1c monitoring in each trimester, • Insulin treatment, • Pregnancies planning, • Diabetes management by a diabetes (i.”
BackgroundInfluentialBr, R., Rowbotham, C. J. F., & Ah, B. (1987) · PubMed · Cited by 15
Treatment of pregnant insulin-dependent diabetic women
Fuhrmann, K. (1986) · European Journal of Endocrinology · doi:10.1530/acta.0.111s0074 · Cited by 10 · cited 2×
“In addition to glycemic control, ten studies included screening and treatment of complications of diabetes in the PPC program [29, 42, 45, 50, 53, 55, 56, 58, 61, 62].”
BackgroundResultCongenital Anomalies of the Kidney and Urinary Tract in Children Born Small for Gestational Age
Janchevska, A., Gucev, Z. S., Tasevska-Rmush, L., & Tasic, V. B. (2017) · PRILOZI · doi:10.1515/prilozi-2017-0007 · Cited by 8 · cited 1×
“The association between SGA and congenital malformations, especially those for the heart and the urinary tract, has been documented in published reports [88, 89].”
ResultControl preconcepcional en la diabetes: factores predisponentes y barreras
Falcón, S. C., Guedes, B. V., Alvarado-Martel, D., & Wägner, A. M. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.10.014 · Cited by 8
[Evaluation of the benefits brought by pregnancy planning in type 1 diabetes mellitus].
Jaffiol, C., Baccara, M. T., Renard, É., Apostol, D., Lefebvre, P., Boulot, P., Daurès, J., & Bringer, J. (2000) · PubMed · Cited by 7
Cyganek, K., Katra, B., Hebda-Szydło, A., Janas, I., Trznadel-Morawska, I., Witek, P., Kozek, E., Hohendorff, J., SKUPIEN, J. K., Matejko, B., et al. (2016) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3543 · Cited by 7 · cited 5×
“PCC: First trimester HbA1c: 6.8 ± SD 1.2 (N = 149) CS delivery: (85/149) Congenital malformations: (1/ 149) Miscarriage: (25/149) Instrumental delivery: (11/149) Maternal hypertension: (25/149) Preeclampsia: (13/149) Preterm delivery: (17/149) Serious adverse outcome: (3/ 149) Shoulder dystocia: (0/149) # Perinatal mo…”
BackgroundInfluential[Preconceptional control in diabetic women].
Ingelmo, G., de la Morena, L. H., Vaquero, P. M., Jáñez Furio, M., Grande Aragón, C., & Lf, P. S. (1998) · PubMed · Cited by 6
Preconception care in diabetes: Predisposing factors and barriers
Falcón, S. C., Guedes, B. V., Alvarado-Martel, D., & Wägner, A. M. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.10.015 · Cited by 6
Research works printed but not linked: 8
- International Diabetes Federation, IDF Diabetes Atlas
- National Collaborating Centre for Ws, 2008, Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period
- H Wahabi, 2019, PROSPERO International prospective register of systematic reviews Preconception care for diabetic women for improving maternal and perinatal outcomes: a systematic review and meta-analysis
- JPT Higgins, Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019), Cochrane
- 2015, GRADEpro GDT: GRADEpro Guideline Development Tool
- Review manager (RevMan). Copenhagen (Denmark): The Cochrane Collaboration, Nordic Cochrane Centre; 2014.
- L Hartling, 2012, Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments US
- VM Allen, 2007, Teratogenicity associated with pre-existing and gestational diabetes. Journal of obstetrics and gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada, JOGC, 29, 927
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
“perinatal mortality, small-for-gestational-age births, and neonatal intensive care unit admission (208).”
Background2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metadata
- Authors
- Wahabi, H. A., Fayed, A., Esmaeil, S., Elmorshedy, H., Titi, M. A., Amer, Y. S., Alzeidan, R. A., Alodhayani, A. A., Saeed, E., Bahkali, K. H., Kahili-Heede, M. K., Jamal, A., & Sabr, Y.
- Affiliations
- King Saud Medical City (SA)
- Princess Nourah bint Abdulrahman University (SA)
- King Saud University (SA)
- Saudi Center for Disease Prevention and Control (SA)
- University of Hawaiʻi at Mānoa (US)
- Corresponding author
- Fayed, Amel
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-08-18
- Volume
- 15
- Issue
- 8
- Pages
- e0237571
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7433888
- OpenAlex
- W3062240202
- Cited by
- 130
- References
- 86
- Citations by year
- 2026: 16 · 2025: 42 · 2024: 19 · 2023: 20 · 2022: 18 · 2021: 13 · 2020: 1
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deanship of Scientific research at Princess Nourah Bint Abdulrahman University (Fast track program)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and Neonatal Healthcare
- Keywords
- preconception care, pregestational diabetes, type 1 diabetes, type 2 diabetes, maternal outcomes, perinatal outcomes, congenital malformations, glycemic control, HbA1c, preterm birth, perinatal mortality, antenatal booking, diabetes screening, diabetes complications, health promotion
- MeSH terms
- Female, Health Promotion, Humans, Infant, Newborn, Pregnancy, Pregnancy in Diabetics, Pregnancy Outcome, Prognosis, Program Evaluation, Preconception Care, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.